P E Sanders

672 total citations
20 papers, 526 citations indexed

About

P E Sanders is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, P E Sanders has authored 20 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in P E Sanders's work include HIV/AIDS drug development and treatment (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and HIV Research and Treatment (3 papers). P E Sanders is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and HIV Research and Treatment (3 papers). P E Sanders collaborates with scholars based in United States, Canada and South Korea. P E Sanders's co-authors include M J Hauer, Larry C. Wienkers, Daniel J. Waldon, N A Payne, Charles G. Knutson, Fengmei Hua, Joseph A. Ware, Richard Voorman, Mark P. Grillo and Hai H. Bui and has published in prestigious journals such as Molecular and Cellular Biology, Applied and Environmental Microbiology and Diabetes.

In The Last Decade

P E Sanders

20 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P E Sanders United States 12 214 121 79 78 58 20 526
Isao Yamatsu Japan 14 258 1.2× 136 1.1× 74 0.9× 72 0.9× 24 0.4× 51 834
Stéphane Dhalluin France 11 341 1.6× 233 1.9× 48 0.6× 92 1.2× 26 0.4× 19 919
Atul Khandwala United States 17 261 1.2× 102 0.8× 94 1.2× 65 0.8× 15 0.3× 47 892
Michael W. Voice United Kingdom 12 276 1.3× 166 1.4× 71 0.9× 59 0.8× 16 0.3× 21 710
C Josepovitz United States 14 208 1.0× 92 0.8× 59 0.7× 133 1.7× 23 0.4× 17 535
David C. McMillan United States 19 157 0.7× 137 1.1× 95 1.2× 75 1.0× 13 0.2× 28 732
Masahiro Iwaki Japan 18 271 1.3× 268 2.2× 43 0.5× 304 3.9× 35 0.6× 71 924
Larissa M. Balogh United States 14 247 1.2× 175 1.4× 37 0.5× 279 3.6× 36 0.6× 15 632
Hozeifa Mohamed Hassan China 18 339 1.6× 200 1.7× 54 0.7× 144 1.8× 26 0.4× 36 780
Armin Kern Germany 9 166 0.8× 83 0.7× 69 0.9× 55 0.7× 17 0.3× 11 453

Countries citing papers authored by P E Sanders

Since Specialization
Citations

This map shows the geographic impact of P E Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P E Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P E Sanders more than expected).

Fields of papers citing papers by P E Sanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P E Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P E Sanders. The network helps show where P E Sanders may publish in the future.

Co-authorship network of co-authors of P E Sanders

This figure shows the co-authorship network connecting the top 25 collaborators of P E Sanders. A scholar is included among the top collaborators of P E Sanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P E Sanders. P E Sanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bui, Hai H., P E Sanders, Diane Bodenmiller, et al.. (2018). Direct analysis of PI(3,4,5)P3 using liquid chromatography electrospray ionization tandem mass spectrometry. Analytical Biochemistry. 547. 66–76. 19 indexed citations
2.
Liu, Ying, Kacey J. Prentice, Kyle W. Sloop, et al.. (2017). Synthesis and Characterization of Urofuranoic Acids: In Vivo Metabolism of 2-(2-Carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic Acid (CMPF) and Effects on in Vitro Insulin Secretion. Journal of Medicinal Chemistry. 60(5). 1860–1875. 19 indexed citations
3.
Kusminski, Christine M., Shiuhwei Chen, Risheng Ye, et al.. (2016). MitoNEET-Parkin Effects in Pancreatic α- and β-Cells, Cellular Survival, and Intrainsular Cross Talk. Diabetes. 65(6). 1534–1555. 54 indexed citations
4.
Li, Zhiqiang, Hongqi Zhang, Jing Liu, et al.. (2011). Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity. Molecular and Cellular Biology. 31(20). 4205–4218. 147 indexed citations
5.
Grillo, Mark P., Charles G. Knutson, P E Sanders, et al.. (2003). STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE. Drug Metabolism and Disposition. 31(11). 1327–1336. 69 indexed citations
6.
7.
Voorman, Richard, N A Payne, Larry C. Wienkers, M J Hauer, & P E Sanders. (2001). Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.. PubMed. 29(1). 41–7. 22 indexed citations
8.
Sanders, P E, et al.. (1998). Quantitative analysis quantitation of 2-n-nonyl-1,3-dioxolane by stable-isotope dilution gas chromatography-mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 705(1). 39–45. 5 indexed citations
9.
Voorman, Richard, et al.. (1998). Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A.. PubMed. 26(7). 631–9. 44 indexed citations
10.
Chang, Mayland, et al.. (1997). Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats.. PubMed. 25(2). 228–42. 12 indexed citations
11.
Streeper, Robert T., et al.. (1997). In vitrometabolic transformations of 2,4- dipyrrolidinylp yrimidine : a chemical probe for P450-mediated oxidation of tirilazad mesylate. Xenobiotica. 27(11). 1131–1145. 4 indexed citations
12.
Chang, Mayland, et al.. (1997). Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.. PubMed. 25(7). 814–27. 11 indexed citations
13.
Chang, Mayland, G J Wilson, P E Sanders, et al.. (1997). Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.. PubMed. 25(7). 828–39. 10 indexed citations
14.
Wienkers, Larry C., Rick C. Steenwyk, P E Sanders, & Paul G. Pearson. (1996). Biotransformation of tirilazad in human: 1. Cytochrome P450 3A-mediated hydroxylation of tirilazad mesylate in human liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 982–990. 37 indexed citations
15.
Slatter, J G, Kenneth L. Feenstra, M J Hauer, et al.. (1996). Metabolism of the bisphosphonate ester U-91502 in rats.. Drug Metabolism and Disposition. 24(1). 65–73. 7 indexed citations
16.
Feenstra, Kenneth L., et al.. (1996). Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture.. Drug Metabolism and Disposition. 24(2). 221–231. 6 indexed citations
17.
Koeplinger, Kenneth A., Gordon L. Bundy, Lee S. Banitt, et al.. (1996). In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.. Drug Metabolism and Disposition. 24(2). 187–198. 3 indexed citations
18.
Sanders, P E. (1990). Secondary‐ion mass spectrometry of particle beams. Rapid Communications in Mass Spectrometry. 4(4). 123–124. 9 indexed citations
19.
Hansen, Larry G., John M. Sullivan, P E Sanders, et al.. (1989). Polychlorinated biphenyl contamination of domestic turkeys from building materials. Journal of Agricultural and Food Chemistry. 37(1). 135–139. 11 indexed citations
20.
Swanson, Steven P., et al.. (1987). Preparation and characterization of the deepoxy trichothecenes: deepoxy HT-2, deepoxy T-2 triol, deepoxy T-2 tetraol, deepoxy 15-monoacetoxyscirpenol, and deepoxy scirpentriol. Applied and Environmental Microbiology. 53(12). 2821–2826. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isao Yamatsu Breakdown of academic impact, for papers by Stéphane Dhalluin Breakdown of academic impact, for papers by Atul Khandwala Breakdown of academic impact, for papers by Michael W. Voice Breakdown of academic impact, for papers by C Josepovitz Breakdown of academic impact, for papers by David C. McMillan Breakdown of academic impact, for papers by Masahiro Iwaki Breakdown of academic impact, for papers by Larissa M. Balogh Breakdown of academic impact, for papers by Hozeifa Mohamed Hassan Breakdown of academic impact, for papers by Armin Kern
Rankless by CCL
2026